Cue Biopharma CUE

$ 1.08 5.93%

Quarterly report 2024-Q3
added 11-14-2024

Cue Biopharma Income Statement 2011-2024 | CUE

Annual Income Statement Cue Biopharma

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	86.5 M	108 M	354 M	388 M	337 M	101 M	311 M	-	-	-	-	-	-
Shares	45.8 M	35.6 M	31.3 M	28.7 M	22 M	20.1 M	20.6 M	-	-	-	-	-	-
Historical Prices	1.89	3.04	11.3	12.5	15.9	4.7	-	-	-	-	-	-	-
Net Income	-50.7 M	-53 M	-44.2 M	-44.8 M	-36.7 M	-39 M	-23.2 M	-7.66 M	-1.93 M	-	-	-	-
Revenue	5.49 M	1.24 M	14.9 M	3.15 M	3.46 M	1.14 M	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	3.15 M	-	-	-	-	-	-	-	-	-
Operating Income	-52.1 M	-53.2 M	-43.7 M	-45 M	-36.8 M	-38.7 M	-23.2 M	-	-	-	-	-	-
Interest Expense	130 K	109 K	-	-	64.1 K	165 K	-	-	-	-	-	-	-
EBITDA	-51.6 M	-52.3 M	-42.5 M	-44 M	-31.6 M	-37.9 M	-22.8 M	-7.46 M	-1.88 M	-	-	-	-
Operating Expenses	57.6 M	54.5 M	58.7 M	48.2 M	40.2 M	39.8 M	-	-	-	-	-	-	-
General and Administrative Expenses	16.7 M	16.2 M	17.3 M	14.7 M	12.7 M	11.3 M	4.33 M	1.97 M	425 K	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Cue Biopharma

	2024-Q3	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	51.2 M	50.2 M	47.2 M	46.4 M	44.8 M	44.7 M	43 M	35.4 M	35.4 M	32.6 M	32.2 M	31.3 M	31.2 M	30.4 M	30.4 M	29.7 M	28.2 M	26.6 M	26.6 M	22.5 M	20.8 M	20.7 M	20.7 M	20.1 M	20.1 M	20.1 M	19.5 M	10.6 M	10.6 M	10.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-8.66 M	-10.2 M	-	-11 M	-13.2 M	-13.1 M	-	-11 M	-13.2 M	-14.3 M	-	-13 M	-10.3 M	-12.5 M	-	-10 M	-10.8 M	-12.8 M	-	-6.99 M	-9.52 M	-11.3 M	-	-12.6 M	-7.3 M	-7.52 M	-	-5.03 M	-4.41 M	-3.35 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	3.34 M	2.66 M	-	2.1 M	1.38 M	187 K	-	68 K	26 K	1 M	-	2.4 M	2.74 M	1.55 M	-	704 K	1.08 M	900 K	-	984 K	1.06 M	370 K	-	449 K	172 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-8.82 M	-10.4 M	-	-11.4 M	-13.5 M	-13.4 M	-	-11 M	-13.1 M	-14.2 M	-	-13 M	-10.3 M	-12.5 M	-	-10.1 M	-10.9 M	-13 M	-	-7.09 M	-9.23 M	-11.4 M	-	-12.8 M	-7.47 M	-7.52 M	-	-5.03 M	-4.41 M	-3.35 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-188 K	-215 K	-	-286 K	-232 K	330 K	-	33 K	33 K	-25 K	-	-	-	-	-	-23 K	-25 K	-26 K	-	5 K	26 K	46 K	-	98 K	2 K	-1 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-8.72 M	-10.3 M	-	-11.3 M	-13.4 M	-13.2 M	-	-10.8 M	-12.9 M	-13.9 M	-	-12.1 M	-10.1 M	-12.2 M	-	-9.33 M	-10.4 M	-12.7 M	-	-6.49 M	-8.82 M	-11.2 M	-	-12.6 M	-7.28 M	-7.36 M	-	-4.74 M	-4.24 M	-3.28 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	12.2 M	13 M	-	13.5 M	14.9 M	13.6 M	-	11.1 M	13.1 M	15.2 M	-	15.4 M	13 M	14.1 M	-	10.8 M	12 M	13.9 M	-	8.08 M	10.3 M	11.8 M	-	13.2 M	7.64 M	7.52 M	-	5.03 M	4.41 M	3.35 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	2.87 M	3.51 M	-	3.64 M	4.25 M	4.18 M	-	3.53 M	3.78 M	5.16 M	-	4.12 M	4.28 M	4.26 M	-	3.32 M	3.9 M	3.99 M	-	2.78 M	3.42 M	3.44 M	-	2.9 M	2.23 M	1.7 M	-	1.03 M	996 K	889 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency